文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

[葛根素减轻APP/PS1转基因小鼠的认知障碍和tau蛋白过度磷酸化]

[Puerarin alleviates cognitive impairment and tau hyperphosphorylation in APP/PS1 transgenic mice].

作者信息

Mei Zheng-Rong, Tan Xiang-Ping, Liu Shao-Zhi, Huang Han-Hui

机构信息

Department of Pharmacy, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2016 Sep;41(17):3285-3289. doi: 10.4268/cjcmm20161727.


DOI:10.4268/cjcmm20161727
PMID:28920384
Abstract

To observe the effect of puerarin on learning and memory function and tau phosphorylation in APP/PS1 transgenic mice, drugs were administered to 3-month old APP/PS1 transgenic mice. Learning and memory function of mice were assessed by Morris water maze test 3 months after treatment. Animals were decapitated after behavioral test. The levels of Aβ were detected by ELISA, the expression of protein [tau, phosphorylated tau, GSK3β and p-GSK3β(Ser9)] were assessed by Western blot. Morris water maze test showed that the escape latency of APP/PS1 double transgenic mice was significantly longer than that of the normal control group, and the residence time of the original quadrant was significantly shorter. The escape latency of puerarin group was significantly shorter and the residence time of the original quadrant was prolonged compared with the model group. Compared with the normal control group, the levels of Aβ in the cortex of APP/PS1 transgenic mice were increased, the expression of phosphorylated tau was significantly increased, and the expression of phosphorylated GSK3β(Ser9) protein was decreased. Treatment with puerarin, the latency of APP/PS1 transgenic mice was significantly reduced, the level of Aβ was decreased, the expression of phosphorylated tau was significantly decreased, and the expression of phosphorylated GSK3β(Ser9) protein was increased. Puerarin improves the learning and memory impairment by reducing the formation of Aβ, activating the GSK3β signaling pathway, inhibiting the phosphorylation of tau in APP/PS1 double transgenic mice.

摘要

为观察葛根素对APP/PS1转基因小鼠学习记忆功能及tau蛋白磷酸化的影响,对3月龄APP/PS1转基因小鼠给药。治疗3个月后通过Morris水迷宫试验评估小鼠的学习记忆功能。行为测试后将动物断头。通过ELISA检测Aβ水平,通过蛋白质印迹法评估蛋白质[tau、磷酸化tau、GSK3β和p-GSK3β(Ser9)]的表达。Morris水迷宫试验表明,APP/PS1双转基因小鼠的逃避潜伏期明显长于正常对照组,且在原象限的停留时间明显缩短。与模型组相比,葛根素组的逃避潜伏期明显缩短,在原象限的停留时间延长。与正常对照组相比,APP/PS1转基因小鼠皮质中Aβ水平升高,磷酸化tau的表达明显增加,磷酸化GSK3β(Ser9)蛋白的表达降低。给予葛根素治疗后,APP/PS1转基因小鼠的潜伏期明显缩短,Aβ水平降低,磷酸化tau的表达明显降低,磷酸化GSK3β(Ser9)蛋白的表达增加。葛根素通过减少Aβ的形成、激活GSK3β信号通路、抑制APP/PS1双转基因小鼠中tau蛋白的磷酸化来改善学习记忆障碍。

相似文献

[1]
[Puerarin alleviates cognitive impairment and tau hyperphosphorylation in APP/PS1 transgenic mice].

Zhongguo Zhong Yao Za Zhi. 2016-9

[2]
Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.

Metab Brain Dis. 2016-6

[3]
Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.

Exp Gerontol. 2016-11

[4]
Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice.

Int J Neuropsychopharmacol. 2014-4

[5]
Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.

J Alzheimers Dis. 2020

[6]
FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.

PLoS One. 2013-11-4

[7]
Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.

J Ethnopharmacol. 2019-11-27

[8]
Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.

Pharmacol Res. 2018-10-28

[9]
Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.

Med Sci Monit. 2018-8-13

[10]
HDAC6 modulates the cognitive behavioral function and hippocampal tissue pathological changes of APP/PS1 transgenic mice through HSP90-HSF1 pathway.

Exp Brain Res. 2024-8

引用本文的文献

[1]
Traditional Chinese Medicine-derived formulations and extracts modulating the PI3K/AKT pathway in Alzheimer's disease.

Front Pharmacol. 2025-3-17

[2]
Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases.

Mol Neurobiol. 2024-12

[3]
Research progress in traditional Chinese medicine in the treatment of Alzheimer's disease and related dementias.

Front Pharmacol. 2022-11-24

[4]
Neurodevelopmental copy-number variants: A roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact.

Am J Hum Genet. 2022-8-4

[5]
Neuroprotective Mechanisms of Puerarin in Central Nervous System Diseases: Update.

Aging Dis. 2022-7-11

[6]
Natural Compounds for Alzheimer's Disease Therapy: A Systematic Review of Preclinical and Clinical Studies.

Int J Mol Sci. 2019-5-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索